| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | Chief Operating Officer | Chief Operating Officer
1 company
Tessari Eben is a Chief Strategy Officer at KNSA. Recent filings cover 0 purchases and 34 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Tessari Eben a below-average insider score of 32/100, based on 27 past trades. Over a 12-month horizon, 5.9% of those trades were profitable, with an average 12-month return of -75.4%.
Tessari Eben's largest disclosed position is in KNSA as Chief Strategy Officer, worth about $1.1M. The recent filings there lean toward selling, a net 628,733 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 17,000 | $26.87 | $456,790.00 | -13.4% | -32.9% | +43.6% | |
| Sep 23, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 17,500 | $24.99 | $437,325.00 | -13.0% | -17.7% | +47.6% | |
| Aug 27, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 17,500 | $26.91 | $470,925.00 | -12.7% | -19.4% | +24.5% | |
| Mar 1, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 1,189 | $22.03 | $26,193.67 | -1.0% | -14.6% | -6.7% |